Today: 9 June 2026
USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape
3 February 2026
2 mins read

USA Rare Earth stock jumps 16% as Trump’s Project Vault plan puts rare earths back on the tape

New York, Feb 3, 2026, 12:53 PM (EST) — Regular session.

  • USA Rare Earth shares continue their rollercoaster ride as traders pile into rare earth plays tied to Washington
  • White House announces “Project Vault” to build a stockpile of critical minerals, backed by Ex-Im financing and private investors
  • Attention shifts to purchase terms, timing, and upcoming policy cues from Washington

Shares of USA Rare Earth (USAR.O) jumped roughly 16% on heavy volume Tuesday, boosted by renewed U.S. efforts to build up critical mineral reserves. By midday in New York, the stock climbed $3.53 to $25.64.

The move came after President Donald Trump unveiled “Project Vault,” aiming to create a strategic reserve of critical minerals. The plan features a $10 billion loan from the U.S. Export-Import Bank, alongside $2 billion in private investment. According to a Trump administration official familiar with the initiative, commodities traders like Hartree Partners, Traxys North America, and Mercuria Energy Group will manage procurement. Reuters

Trump introduced the plan as a safeguard against supply disruptions. “Today, we’re launching what will be known as Project Vault to ensure that American businesses and workers are never harmed by any shortage,” he declared from the White House. Interior Secretary Doug Burgum added that 11 more countries will join a critical minerals trade club, with details coming later this week. Reuters

Export-Import Bank Chairman John Jovanovic described the program as a way to “support U.S. production and processing of critical raw materials, and strengthen America’s critical minerals sector.” Still, analysts and investors remain uncertain about the pricing mechanics and how heavily the program will be utilized after the initial buzz dies down. Axios

Shares of other U.S.-listed companies linked to the theme climbed as well. MP Materials rose around 6%, with Energy Fuels and American Resources both jumping close to 14%.

USA Rare Earth produces sintered neodymium magnets and is constructing a neodymium‑iron‑boron (NdFeB) magnet facility in Stillwater, Oklahoma. The company’s goal: to secure a larger slice of the U.S. rare-earth supply chain. NdFeB magnets play a key role in electric motors and other industries that rely on powerful permanent magnets.

The stock ended Monday at $22.11, after trading within a range of $21.79 to $26.02. This kind of volatility has become routine over the past two weeks, as policy news initially moves the price before traders dissect the details.

The company has already reaped benefits from Washington’s push on critical minerals. Just last week, it announced the Trump administration would support a $1.6 billion debt-and-equity package to build its mine and magnet facilities. The government’s backing comes with shares and warrants.

The company also announced the closing of a $1.5 billion private investment in public equity, or PIPE, financing — a discounted share sale to private investors frequently used for rapid capital raises.

But the policy trade swings both ways. Inside the administration, debate over whether to implement price floors—minimum price guarantees aimed at backing domestic projects—has rattled the sector. Investors are still left in the dark about Project Vault’s purchase terms, complicating demand forecasts.

The next major event hits Wednesday, as Secretary of State Marco Rubio hosts a ministerial meeting on critical minerals at the State Department. Vice President JD Vance is expected to give the keynote. Traders will be on the lookout for specifics on Project Vault: what it will buy, which players are on board, and how quickly federally supported demand will hit the market.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Previous Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today
Next Story

Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today

Go toTop